Evidence map›Paper›PMID 31492503›Full record

ArticleLancet (London, England)2020

Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.

Salim Yusuf, Philip Joseph, Sumathy Rangarajan, Shofiqul Islam, Andrew Mente, Perry Hystad, Michael Brauer, Vellappillil Raman Kutty, Rajeev Gupta, Andreas Wielgosz and 29 more

Erratum issued 4 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Lancet (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 4 registered trials, which are not on this map. Cited by 1,076 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,076citing papers in PubMed, 4 pooled it
93.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04505150 naunknown statusnot on this map

Lowering Blood Pressure by Changing Lifestyle Through a Motivational Education Program: a Cluster RCT Study Protocol

TypeinterventionalSponsorOrganisation for Rural Community Development, BangladeshRan2020 to 2022Enrolled300ConditionsHigh Blood PressureArmsLifestyle changes, e.g., take part in regular exercise, quitting smoking, and reduce salt consumption
NCT05395806 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Effectiveness of a Gamified App for Cardiovascular Disease Management in Primary Care: a Randomized Clinical Trial

TypeinterventionalSponsorPontificia Universidad Catolica de ChileRan2021 to 2024Enrolled900ConditionsCardiovascular Diseases, Compliance, Medication, Physical Inactivity, HypertensionArmsHealth App, Usual Care
NCT05515653 unknown statusnot on this mapstarted 2022, after this paper: background citation

Impact of the Genetic Background as a Risk Factor for Atherosclerotic Cardiovascular Disease in the Brazilian Population

TypeobservationalSponsorHospital Alemão Oswaldo CruzRan2022 to 2024Enrolled3,974ConditionsCardiovascular Diseases, Acute MI, Stroke, Peripheral Arterial DiseaseArmsExposure to genetics (polygenic)
NCT06509282 nacompletednot on this mapstarted 2023, after this paper: background citation

Efficacy of a Personalized Concurrent Exercise Prescription Guide for Controlling Cardiovascular Risk and Enhancing Physical Fitness in Adults From a Cardiovascular Health Program: A Pilot Randomized Controlled Clinical Trial.

TypeinterventionalSponsorUniversidad San SebastiánRan2023 to 2024Enrolled39ConditionsCardiovascular Syndrome, MetabolicArmsConcurrent training
3 · Its place in the literature

Who cites it

1,076 citing papers in PubMed, 4 syntheses or guidelines pooled it, 1,890 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Proteomic markers associated with blood pressure, hypertension, and treatment-resistant hypertension.American heart journal plus : cardiology research and practice · 2026
    Article
  16. Differences in Office and Ambulatory Pulse Wave Analysis in Patients with White Coat Hypertension and Other Hypertension Phenotypes.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2026
    Article
  17. Article
  18. Beyond the guidelines: Vascular function as the central determinant and therapeutic target in hypertension.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Review
  19. Article
  20. Article

1,016 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

39 authors at 20 institutions in 23 countries.

Salim YusufPopulation Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada. Electronic address: yusufs@mcmaster.ca.
Philip JosephPopulation Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.
Sumathy RangarajanPopulation Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.
Shofiqul IslamPopulation Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.
Andrew MentePopulation Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.
Perry HystadSchool of Biological and Population Health Sciences, College of Public Health and Human Sciences, Oregon State University, Corvallis, OR, USA.
Michael BrauerSchool of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Vellappillil Raman KuttyHealth Action by People, Trivandrum, India.
Rajeev GuptaEternal Heart Care Centre & Research Institute, Jaipur, India.
Andreas WielgoszDepartment of Medicine, University of Ottawa, Ottawa, ON, Canada.
Khalid F AlHabibDepartment of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Antonio DansDepartment of Cardiac Sciences, University of Philippines, Manila, Philippines.
Patricio Lopez-JaramilloFundación Oftalmológica de Santander Clínica Carlos Ardila Lulle (FOSCAL), Bucaramanga, Colombia; Escuela de Medicina, Universidad de Santander, Bucaramanga, Colombia.
Alvaro AvezumDepartment of Medicine, Universidade de Santo Amaro, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.
Fernando LanasDepartment of Medicine, Universidad de La Frontera, Temuco, Chile.
Aytekin OguzDepartment of Internal Medicine, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
Iolanthe M KrugerAfrica Unit for Transdisciplinary Health Research (AUTHeR), North-West University, Potchefstroom, South Africa.
Rafael DiazEstudios Clínicos Latinoamérica (ECLA), Rosario, Santa Fe, Argentina.
Khalid YusoffFaculty of Medicine, Universiti Teknologi MARA, Selangor, Malaysia; UCSI University, Cheras, Kuala Lumpur, Malaysia.
Prem MonySt John's Research Institute, St John's Medical College, Bangalore, India.
Jephat ChifambaPhysiology Department, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
Karen YeatesDepartment of Medicine, Queen's University, Kingston, ON, Canada.
Roya KelishadiIsfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Afzalhussein YusufaliDepartment of Medicine, Dubai Medical University, Hatta Hospital, Dubai Health Authority, Dubai, United Arab Emirates.
Rasha KhatibInstitute for Community and Public Health, Birzeit University, Birzeit, Palestine; Advocate Health Care, Chicago, IL, USA.
Omar RahmanIndependent University, Dhaka, Bangladesh.
Katarzyna ZatonskaDepartment of Social Medicine, Wroclaw Medical University, Wroclaw, Poland.
Romaina IqbalDepartment of Community Health Sciences and Medicine, Aga Khan University, Karachi, Pakistan.
Li WeiNational Centre for Cardiovascular Diseases, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Hu BoNational Centre for Cardiovascular Diseases, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Annika RosengrenDepartment of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.
Manmeet KaurSchool of Public Health, Post Graduate Institute of Medical Education & Research, Chandigarh, India.
Viswanathan MohanMadras Diabetes Research Foundation, Chennai, India; Dr Mohan's Diabetes Specialities Centre, Chennai, India.
Scott A LearFaculty of Health Sciences, Simon Fraser University, Vancouver, BC, Canada.
Koon K TeoPopulation Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.
Darryl LeongPopulation Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.
Martin O'DonnellDepartment of Medicine, National University of Ireland Galway, London, UK.
Martin McKeeDepartment of Public Health, London School of Hygiene & Tropical Medicine, London, UK.
Gilles DagenaisInstitut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Quebec, QC, Canada.
Population Health Research Institute · CAChinese Academy of Medical Sciences & Peking Union Medical College · CNHamilton Health Sciences · CAMcMaster University · CAAga Khan University · PKBirzeit University · PSDubai Health Authority · AEEstudios Clínicos Latinoamérica · AREternal Hospital · INHealth Action by People · INHospital Alemão Oswaldo Cruz · BRIndependent University · BDInstitut universitaire de cardiologie et de pneumologie de Québec · CAIsfahan University of Medical Sciences · IRIstanbul Medeniyet University · TRKing Saud University · SALondon School of Hygiene & Tropical Medicine · GBMadras Diabetes Research Foundation · INNorth-West University · ZAOllscoil na Gaillimhe – University of Galway · IE

Funding

PURE-AIR: A Global Assessment of Air Pollution and Cardiopulmonary DiseaseDP5OD019850 · OD · OREGON STATE UNIVERSITY · PI HYSTAD, PERRY W · 2014 to 2018
$1.7M
NIH HHS DP5 OD019850
6 · The paper itself

Abstract

backgroundGlobal estimates of the effect of common modifiable risk factors on cardiovascular disease and mortality are largely based on data from separate studies, using different methodologies. The Prospective Urban Rural Epidemiology (PURE) study overcomes these limitations by using similar methods to prospectively measure the effect of modifiable risk factors on cardiovascular disease and mortality across 21 countries (spanning five continents) grouped by different economic levels.

methodsIn this multinational, prospective cohort study, we examined associations for 14 potentially modifiable risk factors with mortality and cardiovascular disease in 155 722 participants without a prior history of cardiovascular disease from 21 high-income, middle-income, or low-income countries (HICs, MICs, or LICs). The primary outcomes for this paper were composites of cardiovascular disease events (defined as cardiovascular death, myocardial infarction, stroke, and heart failure) and mortality. We describe the prevalence, hazard ratios (HRs), and population-attributable fractions (PAFs) for cardiovascular disease and mortality associated with a cluster of behavioural factors (ie, tobacco use, alcohol, diet, physical activity, and sodium intake), metabolic factors (ie, lipids, blood pressure, diabetes, obesity), socioeconomic and psychosocial factors (ie, education, symptoms of depression), grip strength, and household and ambient pollution. Associations between risk factors and the outcomes were established using multivariable Cox frailty models and using PAFs for the entire cohort, and also by countries grouped by income level. Associations are presented as HRs and PAFs with 95% CIs.

findingsBetween Jan 6, 2005, and Dec 4, 2016, 155 722 participants were enrolled and followed up for measurement of risk factors. 17 249 (11·1%) participants were from HICs, 102 680 (65·9%) were from MICs, and 35 793 (23·0%) from LICs. Approximately 70% of cardiovascular disease cases and deaths in the overall study population were attributed to modifiable risk factors. Metabolic factors were the predominant risk factors for cardiovascular disease (41·2% of the PAF), with hypertension being the largest (22·3% of the PAF). As a cluster, behavioural risk factors contributed most to deaths (26·3% of the PAF), although the single largest risk factor was a low education level (12·5% of the PAF). Ambient air pollution was associated with 13·9% of the PAF for cardiovascular disease, although different statistical methods were used for this analysis. In MICs and LICs, household air pollution, poor diet, low education, and low grip strength had stronger effects on cardiovascular disease or mortality than in HICs.

interpretationMost cardiovascular disease cases and deaths can be attributed to a small number of common, modifiable risk factors. While some factors have extensive global effects (eg, hypertension and education), others (eg, household air pollution and poor diet) vary by a country's economic level. Health policies should focus on risk factors that have the greatest effects on averting cardiovascular disease and death globally, with additional emphasis on risk factors of greatest importance in specific groups of countries.

fundingFull funding sources are listed at the end of the paper (see Acknowledgments).

Indexed as

Developed CountriesDeveloping CountriesHealth PolicySocioeconomic FactorsAdultAgedCardiovascular DiseasesCohort StudiesEducational StatusEnvironmental ExposureFemaleHealth BehaviorHumansHypertensionIncomeMale

Identifiers

PMID31492503
PMCPMC8006904
OpenAlexW2971576504

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.